Chemerin in human cardiovascular disease
- 1 November 2018
- journal article
- review article
- Published by Elsevier in Vascular Pharmacology
- Vol. 110, 1-6
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- Chemerin: at the crossroads of inflammation and obesityTrends in Endocrinology & Metabolism, 2010
- Chemerin, a Novel Adipokine in the Regulation of AngiogenesisThe Journal of Clinical Endocrinology & Metabolism, 2010
- Identification of chemerin receptor (ChemR23) in human endothelial cells: Chemerin-induced endothelial angiogenesisBiochemical and Biophysical Research Communications, 2010
- Chemerin Is Associated with Metabolic Syndrome Phenotypes in a Mexican-American PopulationThe Journal of Clinical Endocrinology & Metabolism, 2009
- Regulation of Chemerin Bioactivity by Plasma Carboxypeptidase N, Carboxypeptidase B (Activated Thrombin-activable Fibrinolysis Inhibitor), and PlateletsJournal of Biological Chemistry, 2009
- Mast cell–expressed orphan receptor CCRL2 binds chemerin and is required for optimal induction of IgE-mediated passive cutaneous anaphylaxisJournal of Experimental Medicine, 2008
- Synthetic chemerin-derived peptides suppress inflammation through ChemR23Journal of Experimental Medicine, 2008
- Chemerin enhances insulin signaling and potentiates insulin‐stimulated glucose uptake in 3T3‐L1 adipocytesFEBS Letters, 2008
- The genetic design of signaling cascades to record receptor activationProceedings of the National Academy of Sciences, 2008
- Chemerin—A new adipokine that modulates adipogenesis via its own receptorBiochemical and Biophysical Research Communications, 2007